Product Type: Blocker
CAS No.: 1222781-70-5
MolecularFormula: C19H19NO • HCl
Molecular Weight: 313,8
Source: Synthetic
Purity: >98% (HPLC); NMR (Conforms)
Solubility: May be dissolved in DMSO (32 mg/ml); or water (10 mg/ml, warm)
Appearance: White powder
PubChem CID: 44247466
Scientific Background: A potent and selective blocker of the inwardly rectifying Kir2 potassium channel, IC50s = 1.8, 2.8, 2,9, and 4.0 µM for Kir2.1, Kir2.6, Kir2.2, and Kir2.3, respectively (1). Intrathecal injection of ML133 attenuated the proliferation of microglia and neuropathic pain behaviors after nerve injury (2). ML133 inhibits microglial priming pointing to Kir2.1 channels as a new therapeutic target for neuronal damage (3). Moreover, treatment with ML133 one hour post-injury was sufficient to improve neuronal survival in a traumatic brain injury human organoid model (4).
References: 1. Wang H.R. et al. 2011. ACS Chem. Biol. 6:845.2. Gattlen C. et al. (2020) Glia 68:2119.3. Spencer N.G. et al. (2016) PLoS One. 11(9):e0162497.4. Lai J.D. et al. 2024. Cell Stem Cell 31:519.
Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
English
Deutsch
